This investigation was a retrospective analysis of 145 patients with OAG and 60 healthy controls who were enrolled from a clinical database at the Glaucoma Clinic of Korea University Anam Hospital, Seoul, Korea, from January 2013 through March 2014. Ethical approval was obtained from the institutional review board. The study was conducted in adherence to the tenets of the Declaration of Helsinki.
All patients underwent comprehensive ophthalmologic examinations, including a detailed review of medical and ocular history, measurement of best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, autorefraction, Goldmann applanation tonometry, central corneal thickness (CCT) measurement using a specular microscope (SP-2000P; Topcon Corporation, Tokyo, Japan), gonioscopy, and standard automated perimetry using the 30-2 Swedish Interactive Threshold Algorithm standard program (Zeiss-Humphrey, San Leandro, CA, USA). Measurements of peripapillary RNFL thickness with spectral-domain optical coherence tomography (SD-OCT; 3D OCT-1000 Mark II, software version 3.20; Topcon Corp.), dilated 30° stereoscopic photography, and 50° red-free photography (model FF 450 Plus; Carl Zeiss Meditec AG, Jena, Germany) were also conducted.
Participants included in this study met the following criteria: BCVA of greater than 20/40; a spherical equivalent (SE) between −6.0 and +4.0 diopters (D); a cylinder correction within ± 3.0 D; the presence of a normal anterior chamber and an open angle; and at least two reliable VF test results with a false-positive error less than 15%, a false-negative error less than 15%, and a fixation loss less than 20%. Subjects were excluded if they had any of the following criteria: (1) a history of ocular trauma or ocular surgery, (2) a history of any retinal disease such as diabetic retinopathy, retinal vessel occlusion, or epiretinal membrane, (3) media opacity that could affect the quality of photography, (4) optic nerve disease other than glaucoma, or (5) a history of a cerebrovascular event or systemic medication use that could affect the VF. In cases with both eyes eligible for the study, one eye was randomly chosen for inclusion.
A glaucomatous VF change was defined as the consistent presence of a cluster of three or more nonedge points on a pattern deviation plot, with a less than 5% probability of occurrence in the healthy population; a pattern standard deviation (PSD) with P less than 5%; or a glaucoma hemifield test result outside of normal limits. According to the mean deviation (MD) of the VF, the stage of glaucoma was categorized into three subgroups including early (MD ≥ −6 dB), moderate (−12 ≤ MD < −6 dB), and severe glaucoma (MD < −12 dB), as confirmed by at least two reliable VF examinations.
Open-angle glaucoma was diagnosed by a glaucoma specialist (CY) when a glaucomatous VF loss was present combined with a corresponding glaucomatous optic-disc change (neuroretinal rim thinning, notching, and excavation) or a nerve fiber layer defect. Gonioscopy was used to exclude angle closure, rubeosis, and secondary glaucoma. According to the baseline untreated IOP, the patients with OAG were categorized into two subgroups, HTG and LTG. High-tension glaucoma was defined as OAG with a baseline IOP of greater than or equal to 20 mm Hg, whereas LTG had an IOP of less than 20 mm Hg, on the basis of the Namil Study, which was a cross-sectional epidemiologic study conducted in the Namil–Myon area of central South Korea.
32 Data of healthy control eyes were obtained from the subjects who were referred to our clinic for a routine checkup. Inclusion criteria for healthy controls were an IOP less than 20 mm Hg without a history of increased IOP, an absence of a glaucomatous disc appearance, no visible RNFL defect on red-free photography, and a normal VF result.